Article

MIGS + medication provides IOP-lowering benefit

The Oculus Corvis ST, a non-contact tonometer and optical pachymeter, has received the approval of the U.S. FDA.

 

Wetzlar, Germany-The Oculus Corvis ST, a non-contact tonometer and optical pachymeter, has received the approval of the U.S. FDA.

The approval was based on a study at the University of Freiburg that proved exceptionally high precision of the IOP measurements in comparison with the Goldmann applanation tonometer.

This precision was achieved by using the new measurement principle of the Corvis ST, where the reaction of the cornea due to an air pulse is visualized with a high-speed Scheimpflug camera. This allows a more accurate determination of the exact time of the first applanation of the cornea compared with conventional non-contact tonometers. This precision is also basis for the accurate determination of the IOP.

For more information, see www.oculus.de or www.oculususa.com.

 

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
© 2025 MJH Life Sciences

All rights reserved.